| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 113 | 2025 | 272 | 17.590 |
Why?
|
| Environmental Exposure | 84 | 2025 | 355 | 11.190 |
Why?
|
| Water Pollutants, Chemical | 58 | 2025 | 140 | 10.290 |
Why?
|
| Bangladesh | 143 | 2025 | 339 | 7.940 |
Why?
|
| Arsenic Poisoning | 38 | 2023 | 104 | 7.570 |
Why?
|
| Drinking Water | 29 | 2025 | 70 | 6.270 |
Why?
|
| Skin Diseases | 23 | 2019 | 174 | 4.940 |
Why?
|
| Water Supply | 30 | 2021 | 66 | 3.870 |
Why?
|
| Polymorphism, Single Nucleotide | 53 | 2025 | 2484 | 3.520 |
Why?
|
| Genetic Predisposition to Disease | 51 | 2024 | 2465 | 3.130 |
Why?
|
| Genome-Wide Association Study | 37 | 2025 | 1762 | 2.960 |
Why?
|
| Cardiovascular Diseases | 25 | 2025 | 751 | 2.920 |
Why?
|
| Breast Neoplasms | 34 | 2024 | 3110 | 2.580 |
Why?
|
| Middle Aged | 180 | 2025 | 27569 | 2.480 |
Why?
|
| Cohort Studies | 69 | 2025 | 3054 | 2.440 |
Why?
|
| Adult | 170 | 2025 | 27918 | 2.400 |
Why?
|
| Female | 232 | 2025 | 48698 | 2.390 |
Why?
|
| Smoking | 26 | 2024 | 648 | 2.380 |
Why?
|
| Risk Factors | 97 | 2025 | 5898 | 2.330 |
Why?
|
| Diet | 14 | 2024 | 460 | 2.270 |
Why?
|
| Prospective Studies | 70 | 2025 | 4560 | 2.270 |
Why?
|
| Male | 206 | 2025 | 44553 | 2.270 |
Why?
|
| Humans | 316 | 2025 | 93511 | 2.210 |
Why?
|
| DNA Methylation | 26 | 2024 | 697 | 2.180 |
Why?
|
| Longitudinal Studies | 49 | 2024 | 1161 | 2.160 |
Why?
|
| Dyspnea | 5 | 2017 | 86 | 1.970 |
Why?
|
| Arsenicals | 13 | 2023 | 49 | 1.960 |
Why?
|
| Body Mass Index | 22 | 2025 | 811 | 1.800 |
Why?
|
| Air Pollution | 8 | 2024 | 107 | 1.730 |
Why?
|
| Precancerous Conditions | 7 | 2010 | 205 | 1.680 |
Why?
|
| Neoplasms | 23 | 2025 | 3169 | 1.660 |
Why?
|
| Skin Neoplasms | 10 | 2025 | 620 | 1.610 |
Why?
|
| Aged | 97 | 2025 | 20430 | 1.590 |
Why?
|
| Air Pollutants | 7 | 2024 | 108 | 1.540 |
Why?
|
| Genotype | 27 | 2019 | 1866 | 1.440 |
Why?
|
| Gene-Environment Interaction | 6 | 2025 | 120 | 1.400 |
Why?
|
| Blood Pressure | 13 | 2024 | 896 | 1.370 |
Why?
|
| Particulate Matter | 8 | 2024 | 123 | 1.370 |
Why?
|
| Water Pollution, Chemical | 8 | 2015 | 21 | 1.370 |
Why?
|
| Quantitative Trait Loci | 5 | 2022 | 630 | 1.350 |
Why?
|
| Selenium | 9 | 2019 | 46 | 1.330 |
Why?
|
| Colorectal Neoplasms | 11 | 2024 | 1053 | 1.310 |
Why?
|
| Genome, Human | 11 | 2019 | 823 | 1.280 |
Why?
|
| Mortality | 7 | 2021 | 156 | 1.280 |
Why?
|
| Case-Control Studies | 39 | 2023 | 1931 | 1.250 |
Why?
|
| Methyltransferases | 8 | 2025 | 213 | 1.240 |
Why?
|
| Young Adult | 44 | 2025 | 6930 | 1.240 |
Why?
|
| Telomere | 10 | 2025 | 120 | 1.230 |
Why?
|
| Proportional Hazards Models | 23 | 2025 | 889 | 1.220 |
Why?
|
| Adolescent | 47 | 2025 | 9606 | 1.210 |
Why?
|
| Asia | 27 | 2025 | 107 | 1.210 |
Why?
|
| Oryza | 4 | 2019 | 44 | 1.190 |
Why?
|
| Food Contamination | 4 | 2019 | 35 | 1.180 |
Why?
|
| Carotid Intima-Media Thickness | 9 | 2018 | 39 | 1.180 |
Why?
|
| Cross-Sectional Studies | 37 | 2024 | 1847 | 1.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2024 | 1225 | 1.120 |
Why?
|
| Lung Diseases | 3 | 2016 | 283 | 1.110 |
Why?
|
| Antioxidants | 4 | 2013 | 231 | 1.080 |
Why?
|
| Proteinuria | 3 | 2015 | 69 | 1.060 |
Why?
|
| Vitamin B Complex | 7 | 2010 | 21 | 1.060 |
Why?
|
| Rural Population | 12 | 2023 | 170 | 1.030 |
Why?
|
| Incidence | 22 | 2025 | 1701 | 1.020 |
Why?
|
| Thinness | 5 | 2022 | 45 | 0.990 |
Why?
|
| Genotyping Techniques | 2 | 2017 | 71 | 0.950 |
Why?
|
| Dietary Proteins | 3 | 2012 | 31 | 0.940 |
Why?
|
| Prevalence | 19 | 2024 | 1321 | 0.940 |
Why?
|
| Folic Acid | 9 | 2019 | 62 | 0.930 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2017 | 691 | 0.890 |
Why?
|
| Keratosis | 4 | 2012 | 21 | 0.870 |
Why?
|
| Microsatellite Instability | 2 | 2024 | 64 | 0.860 |
Why?
|
| Environmental Monitoring | 10 | 2024 | 89 | 0.860 |
Why?
|
| Biomarkers, Tumor | 9 | 2018 | 1660 | 0.860 |
Why?
|
| Food | 3 | 2015 | 92 | 0.850 |
Why?
|
| Heart Diseases | 3 | 2016 | 257 | 0.830 |
Why?
|
| Vascular Stiffness | 1 | 2024 | 28 | 0.830 |
Why?
|
| Genetic Variation | 10 | 2022 | 1415 | 0.820 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2025 | 1338 | 0.820 |
Why?
|
| Odds Ratio | 19 | 2019 | 711 | 0.790 |
Why?
|
| Hypertension | 8 | 2024 | 757 | 0.790 |
Why?
|
| Pancreatic Neoplasms | 4 | 2013 | 715 | 0.750 |
Why?
|
| Liver Neoplasms | 14 | 2024 | 776 | 0.740 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 8 | 2019 | 12 | 0.730 |
Why?
|
| Environmental Pollutants | 4 | 2018 | 56 | 0.710 |
Why?
|
| Occupational Exposure | 3 | 2010 | 87 | 0.710 |
Why?
|
| Respiration Disorders | 2 | 2013 | 42 | 0.700 |
Why?
|
| Parity | 6 | 2024 | 97 | 0.700 |
Why?
|
| Methylation | 8 | 2019 | 288 | 0.690 |
Why?
|
| Air Pollution, Indoor | 4 | 2023 | 80 | 0.690 |
Why?
|
| Vitamin E | 4 | 2014 | 34 | 0.680 |
Why?
|
| Transcriptome | 8 | 2025 | 762 | 0.680 |
Why?
|
| Molecular Epidemiology | 5 | 2010 | 57 | 0.660 |
Why?
|
| DNA Adducts | 9 | 2019 | 22 | 0.660 |
Why?
|
| Selenomethionine | 2 | 2013 | 11 | 0.650 |
Why?
|
| Mendelian Randomization Analysis | 5 | 2016 | 50 | 0.650 |
Why?
|
| Manganese | 6 | 2019 | 56 | 0.650 |
Why?
|
| Cause of Death | 10 | 2022 | 273 | 0.630 |
Why?
|
| Gene Expression Profiling | 8 | 2025 | 1518 | 0.630 |
Why?
|
| Sex Factors | 17 | 2021 | 1105 | 0.610 |
Why?
|
| Polymorphism, Genetic | 6 | 2015 | 826 | 0.610 |
Why?
|
| Areca | 6 | 2025 | 11 | 0.610 |
Why?
|
| Thyroid Neoplasms | 5 | 2025 | 442 | 0.600 |
Why?
|
| Water Wells | 6 | 2022 | 18 | 0.600 |
Why?
|
| Ammonia-Lyases | 1 | 2019 | 6 | 0.590 |
Why?
|
| Glutamate Formimidoyltransferase | 1 | 2019 | 6 | 0.590 |
Why?
|
| Telomere Homeostasis | 5 | 2021 | 29 | 0.590 |
Why?
|
| Phenotype | 8 | 2019 | 2544 | 0.590 |
Why?
|
| Carcinoma, Hepatocellular | 12 | 2012 | 418 | 0.580 |
Why?
|
| Alleles | 11 | 2020 | 1139 | 0.580 |
Why?
|
| Meat | 3 | 2024 | 27 | 0.560 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 3 | 2008 | 16 | 0.560 |
Why?
|
| Reproductive History | 4 | 2025 | 12 | 0.550 |
Why?
|
| Aromatase | 3 | 2007 | 12 | 0.550 |
Why?
|
| Research Design | 5 | 2018 | 617 | 0.540 |
Why?
|
| Atherosclerosis | 6 | 2018 | 256 | 0.540 |
Why?
|
| Estrogens | 3 | 2008 | 195 | 0.530 |
Why?
|
| Leukocytes | 7 | 2025 | 210 | 0.530 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 1985 | 0.530 |
Why?
|
| Cacodylic Acid | 8 | 2021 | 22 | 0.520 |
Why?
|
| Aging | 4 | 2020 | 727 | 0.520 |
Why?
|
| Tertiary Prevention | 1 | 2017 | 2 | 0.520 |
Why?
|
| Carcinoma, Basal Cell | 3 | 2024 | 63 | 0.510 |
Why?
|
| Disease | 2 | 2010 | 92 | 0.500 |
Why?
|
| Biomarkers | 14 | 2023 | 1910 | 0.490 |
Why?
|
| Lung Neoplasms | 6 | 2024 | 2365 | 0.490 |
Why?
|
| Placental Lactogen | 2 | 2008 | 12 | 0.490 |
Why?
|
| Carotid Artery Diseases | 4 | 2018 | 100 | 0.490 |
Why?
|
| Age Factors | 13 | 2025 | 1906 | 0.490 |
Why?
|
| Stomach Neoplasms | 3 | 2024 | 308 | 0.480 |
Why?
|
| Chorionic Gonadotropin | 2 | 2008 | 69 | 0.480 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 192 | 0.480 |
Why?
|
| Overweight | 4 | 2023 | 120 | 0.480 |
Why?
|
| Malnutrition | 2 | 2021 | 36 | 0.480 |
Why?
|
| Chicago | 8 | 2024 | 1464 | 0.470 |
Why?
|
| Surveys and Questionnaires | 15 | 2022 | 2802 | 0.460 |
Why?
|
| Mutation | 9 | 2024 | 4272 | 0.460 |
Why?
|
| Occupational Health | 2 | 2024 | 40 | 0.460 |
Why?
|
| Survival Analysis | 4 | 2017 | 1524 | 0.460 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2015 | 1914 | 0.450 |
Why?
|
| Telomere Shortening | 4 | 2021 | 25 | 0.450 |
Why?
|
| Epigenesis, Genetic | 4 | 2019 | 555 | 0.440 |
Why?
|
| Diabetes Mellitus | 8 | 2025 | 767 | 0.440 |
Why?
|
| Social Class | 3 | 2017 | 141 | 0.430 |
Why?
|
| Arm | 2 | 2014 | 97 | 0.430 |
Why?
|
| Placenta | 2 | 2008 | 189 | 0.430 |
Why?
|
| Specimen Handling | 4 | 2019 | 109 | 0.430 |
Why?
|
| Accidents, Occupational | 1 | 2014 | 8 | 0.420 |
Why?
|
| Human Rights Abuses | 1 | 2014 | 2 | 0.420 |
Why?
|
| Industry | 1 | 2014 | 18 | 0.420 |
Why?
|
| Water Quality | 1 | 2014 | 5 | 0.420 |
Why?
|
| Feces | 4 | 2020 | 360 | 0.420 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.420 |
Why?
|
| Bias | 4 | 2011 | 137 | 0.420 |
Why?
|
| Acids | 1 | 2014 | 13 | 0.420 |
Why?
|
| Rural Health | 1 | 2014 | 18 | 0.410 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 381 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2023 | 47 | 0.410 |
Why?
|
| Safety Management | 1 | 2014 | 51 | 0.410 |
Why?
|
| Follow-Up Studies | 10 | 2025 | 3828 | 0.410 |
Why?
|
| Population Surveillance | 3 | 2011 | 213 | 0.410 |
Why?
|
| Women | 1 | 2014 | 26 | 0.410 |
Why?
|
| Respiratory Tract Diseases | 3 | 2025 | 45 | 0.400 |
Why?
|
| Hematuria | 1 | 2014 | 49 | 0.400 |
Why?
|
| Tremor | 2 | 2011 | 22 | 0.400 |
Why?
|
| DNA, Neoplasm | 3 | 2011 | 266 | 0.400 |
Why?
|
| Digestive System Neoplasms | 1 | 2013 | 20 | 0.400 |
Why?
|
| alpha-Tocopherol | 1 | 2013 | 9 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2024 | 1077 | 0.390 |
Why?
|
| Feeding Behavior | 2 | 2015 | 337 | 0.390 |
Why?
|
| Risk Assessment | 16 | 2023 | 2440 | 0.390 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 2013 | 2 | 0.390 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2022 | 208 | 0.390 |
Why?
|
| Diet Records | 2 | 2012 | 20 | 0.380 |
Why?
|
| Aflatoxin B1 | 7 | 2009 | 9 | 0.380 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 71 | 0.380 |
Why?
|
| Bacteria | 5 | 2020 | 509 | 0.380 |
Why?
|
| Population Health | 2 | 2022 | 33 | 0.370 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2020 | 590 | 0.370 |
Why?
|
| DNA Helicases | 3 | 2017 | 89 | 0.370 |
Why?
|
| Glutathione Transferase | 5 | 2025 | 115 | 0.370 |
Why?
|
| Chromosome Aberrations | 3 | 2019 | 350 | 0.360 |
Why?
|
| Violence | 1 | 2014 | 152 | 0.360 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 317 | 0.360 |
Why?
|
| Tissue Fixation | 2 | 2012 | 39 | 0.350 |
Why?
|
| Risk | 9 | 2015 | 657 | 0.350 |
Why?
|
| Formaldehyde | 2 | 2012 | 51 | 0.350 |
Why?
|
| Paraffin Embedding | 2 | 2012 | 77 | 0.350 |
Why?
|
| Obesity | 10 | 2024 | 1018 | 0.350 |
Why?
|
| Genetic Loci | 4 | 2017 | 260 | 0.350 |
Why?
|
| Carcinoma | 2 | 2015 | 439 | 0.340 |
Why?
|
| Methionine | 2 | 2008 | 64 | 0.340 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 225 | 0.340 |
Why?
|
| Essential Tremor | 1 | 2011 | 6 | 0.340 |
Why?
|
| Promoter Regions, Genetic | 4 | 2008 | 962 | 0.340 |
Why?
|
| Seafood | 4 | 2015 | 11 | 0.340 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 7061 | 0.330 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2011 | 80 | 0.330 |
Why?
|
| Sunlight | 2 | 2010 | 27 | 0.330 |
Why?
|
| Cysteine | 2 | 2008 | 145 | 0.320 |
Why?
|
| Gene Frequency | 4 | 2019 | 700 | 0.320 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2015 | 58 | 0.320 |
Why?
|
| Regression Analysis | 7 | 2017 | 579 | 0.320 |
Why?
|
| Carotid Arteries | 2 | 2013 | 131 | 0.320 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2015 | 76 | 0.310 |
Why?
|
| Loss of Heterozygosity | 3 | 2012 | 84 | 0.310 |
Why?
|
| Lung | 3 | 2023 | 1366 | 0.310 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2017 | 176 | 0.310 |
Why?
|
| Pregnancy | 12 | 2024 | 3147 | 0.310 |
Why?
|
| Socioeconomic Factors | 6 | 2024 | 624 | 0.310 |
Why?
|
| Patient Compliance | 1 | 2011 | 237 | 0.310 |
Why?
|
| Health Surveys | 2 | 2011 | 241 | 0.300 |
Why?
|
| Tobacco Smoking | 2 | 2020 | 31 | 0.300 |
Why?
|
| CpG Islands | 9 | 2019 | 168 | 0.300 |
Why?
|
| Prostatic Neoplasms | 5 | 2016 | 1775 | 0.300 |
Why?
|
| Amino Acids | 1 | 2010 | 249 | 0.300 |
Why?
|
| Logistic Models | 9 | 2024 | 1243 | 0.300 |
Why?
|
| DNA | 6 | 2023 | 1265 | 0.290 |
Why?
|
| Reproducibility of Results | 10 | 2019 | 2715 | 0.290 |
Why?
|
| Carcinoma, Papillary | 2 | 2023 | 159 | 0.280 |
Why?
|
| Microbiota | 3 | 2018 | 425 | 0.280 |
Why?
|
| Causality | 3 | 2013 | 82 | 0.280 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 920 | 0.280 |
Why?
|
| Poverty | 3 | 2018 | 193 | 0.280 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2020 | 259 | 0.270 |
Why?
|
| Mental Health | 2 | 2024 | 188 | 0.270 |
Why?
|
| Protein Carbonylation | 1 | 2008 | 10 | 0.270 |
Why?
|
| Anthropometry | 3 | 2019 | 75 | 0.270 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2006 | 44 | 0.270 |
Why?
|
| Gene Amplification | 1 | 2008 | 140 | 0.270 |
Why?
|
| Child | 14 | 2025 | 7355 | 0.270 |
Why?
|
| Receptors, Estrogen | 5 | 2017 | 413 | 0.260 |
Why?
|
| Life Style | 5 | 2024 | 183 | 0.260 |
Why?
|
| Postmenopause | 1 | 2008 | 106 | 0.260 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2006 | 68 | 0.260 |
Why?
|
| Infant Mortality | 1 | 2007 | 66 | 0.260 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2015 | 378 | 0.250 |
Why?
|
| Survival Rate | 3 | 2025 | 1948 | 0.250 |
Why?
|
| Inflammation | 4 | 2024 | 1050 | 0.250 |
Why?
|
| Gene Expression | 2 | 2018 | 1301 | 0.250 |
Why?
|
| Anemia | 1 | 2008 | 134 | 0.250 |
Why?
|
| Multifactorial Inheritance | 5 | 2024 | 202 | 0.250 |
Why?
|
| Groundwater | 2 | 2025 | 14 | 0.250 |
Why?
|
| Age of Onset | 4 | 2018 | 342 | 0.240 |
Why?
|
| Homocysteine | 5 | 2018 | 30 | 0.240 |
Why?
|
| Chronic Disease | 3 | 2020 | 960 | 0.240 |
Why?
|
| Public Health | 4 | 2013 | 153 | 0.240 |
Why?
|
| Tunica Intima | 1 | 2006 | 61 | 0.240 |
Why?
|
| Models, Genetic | 3 | 2018 | 970 | 0.240 |
Why?
|
| Drinking | 3 | 2011 | 34 | 0.240 |
Why?
|
| Interleukin-17 | 2 | 2024 | 109 | 0.240 |
Why?
|
| Smoke | 3 | 2019 | 29 | 0.240 |
Why?
|
| Vegetables | 3 | 2017 | 50 | 0.240 |
Why?
|
| Spectrophotometry, Atomic | 4 | 2013 | 11 | 0.230 |
Why?
|
| Oxygenases | 1 | 2025 | 17 | 0.230 |
Why?
|
| Multimorbidity | 1 | 2025 | 6 | 0.230 |
Why?
|
| Mass Spectrometry | 4 | 2013 | 200 | 0.230 |
Why?
|
| Lymphocytes | 2 | 2009 | 454 | 0.220 |
Why?
|
| Linear Models | 7 | 2025 | 413 | 0.220 |
Why?
|
| Mass Screening | 4 | 2017 | 696 | 0.220 |
Why?
|
| Lithium | 1 | 2025 | 61 | 0.220 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2015 | 56 | 0.220 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 283 | 0.220 |
Why?
|
| Intelligence | 3 | 2011 | 67 | 0.220 |
Why?
|
| Educational Status | 3 | 2022 | 197 | 0.220 |
Why?
|
| Developing Countries | 3 | 2015 | 91 | 0.220 |
Why?
|
| Microsatellite Repeats | 2 | 2024 | 150 | 0.210 |
Why?
|
| Vitamin B 12 | 4 | 2009 | 24 | 0.210 |
Why?
|
| Ovarian Neoplasms | 2 | 2024 | 797 | 0.210 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 19 | 0.210 |
Why?
|
| Hepatitis B | 4 | 2009 | 77 | 0.210 |
Why?
|
| Metals | 1 | 2025 | 102 | 0.210 |
Why?
|
| Gallbladder Neoplasms | 1 | 2024 | 23 | 0.210 |
Why?
|
| Sequence Deletion | 1 | 2025 | 209 | 0.210 |
Why?
|
| Clothing | 1 | 2024 | 7 | 0.210 |
Why?
|
| Epidemiologic Studies | 3 | 2010 | 17 | 0.210 |
Why?
|
| Menarche | 1 | 2024 | 30 | 0.210 |
Why?
|
| Income | 1 | 2024 | 87 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1173 | 0.210 |
Why?
|
| Prognosis | 5 | 2018 | 3910 | 0.200 |
Why?
|
| Cholelithiasis | 1 | 2023 | 36 | 0.200 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2023 | 36 | 0.200 |
Why?
|
| Proteins | 3 | 2010 | 803 | 0.200 |
Why?
|
| Smoking Cessation | 2 | 2019 | 269 | 0.200 |
Why?
|
| Radius Fractures | 1 | 2003 | 34 | 0.200 |
Why?
|
| Petroleum | 1 | 2023 | 25 | 0.200 |
Why?
|
| Demography | 2 | 2015 | 189 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 178 | 0.190 |
Why?
|
| Double-Blind Method | 5 | 2013 | 1729 | 0.190 |
Why?
|
| Functional Laterality | 1 | 2003 | 203 | 0.190 |
Why?
|
| Sex Distribution | 3 | 2013 | 174 | 0.190 |
Why?
|
| Fathers | 1 | 2003 | 44 | 0.190 |
Why?
|
| Confidence Intervals | 4 | 2013 | 217 | 0.190 |
Why?
|
| Metabolome | 1 | 2023 | 62 | 0.180 |
Why?
|
| Insurance Coverage | 1 | 2023 | 142 | 0.180 |
Why?
|
| Maternal Exposure | 3 | 2017 | 63 | 0.180 |
Why?
|
| Residence Characteristics | 2 | 2022 | 212 | 0.180 |
Why?
|
| Health Status | 2 | 2015 | 377 | 0.180 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2025 | 306 | 0.180 |
Why?
|
| Intestinal Neoplasms | 1 | 2022 | 68 | 0.180 |
Why?
|
| Machine Learning | 1 | 2025 | 341 | 0.180 |
Why?
|
| DNA, Bacterial | 2 | 2019 | 232 | 0.180 |
Why?
|
| Oxidative Stress | 2 | 2006 | 467 | 0.180 |
Why?
|
| Vitamin D | 2 | 2022 | 272 | 0.170 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2022 | 64 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 557 | 0.170 |
Why?
|
| Age Distribution | 4 | 2011 | 206 | 0.170 |
Why?
|
| Blood Proteins | 1 | 2021 | 145 | 0.170 |
Why?
|
| Gene Dosage | 3 | 2012 | 211 | 0.170 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2021 | 49 | 0.170 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 482 | 0.170 |
Why?
|
| Gravidity | 1 | 2020 | 7 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 1234 | 0.160 |
Why?
|
| Hemodynamics | 1 | 2024 | 713 | 0.160 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 227 | 0.160 |
Why?
|
| China | 4 | 2024 | 264 | 0.160 |
Why?
|
| Epigenomics | 2 | 2024 | 109 | 0.160 |
Why?
|
| Taiwan | 7 | 2013 | 25 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2017 | 1691 | 0.160 |
Why?
|
| Chemically-Induced Disorders | 1 | 2020 | 2 | 0.160 |
Why?
|
| Poverty Areas | 1 | 2020 | 37 | 0.160 |
Why?
|
| Leiomyoma | 1 | 2024 | 211 | 0.160 |
Why?
|
| Medicare | 1 | 2023 | 455 | 0.160 |
Why?
|
| Information Seeking Behavior | 1 | 2020 | 18 | 0.160 |
Why?
|
| HLA-DR Antigens | 1 | 2019 | 56 | 0.150 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 60 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2024 | 106 | 0.150 |
Why?
|
| Skin | 2 | 2014 | 578 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2022 | 344 | 0.150 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 277 | 0.150 |
Why?
|
| Fruit | 2 | 2017 | 81 | 0.150 |
Why?
|
| Blood | 1 | 2019 | 68 | 0.150 |
Why?
|
| Disease Progression | 1 | 2024 | 1531 | 0.150 |
Why?
|
| Health Education | 3 | 2019 | 105 | 0.150 |
Why?
|
| Child, Preschool | 6 | 2025 | 3829 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 2 | 2011 | 306 | 0.150 |
Why?
|
| Research Subjects | 1 | 2020 | 73 | 0.150 |
Why?
|
| United States | 9 | 2025 | 7619 | 0.150 |
Why?
|
| Multifunctional Enzymes | 1 | 2019 | 7 | 0.150 |
Why?
|
| Data Collection | 3 | 2022 | 370 | 0.150 |
Why?
|
| Autophagy | 1 | 2021 | 172 | 0.150 |
Why?
|
| Organ Specificity | 3 | 2020 | 279 | 0.150 |
Why?
|
| BRCA1 Protein | 2 | 2017 | 214 | 0.150 |
Why?
|
| Diet Surveys | 3 | 2015 | 21 | 0.150 |
Why?
|
| Receptors, Opioid | 1 | 2019 | 23 | 0.150 |
Why?
|
| Fertilizers | 2 | 2010 | 9 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2021 | 235 | 0.150 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 47 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2015 | 580 | 0.140 |
Why?
|
| Administration, Oral | 2 | 2014 | 657 | 0.140 |
Why?
|
| Computer Simulation | 4 | 2018 | 1118 | 0.140 |
Why?
|
| Receptors, Adiponectin | 2 | 2008 | 4 | 0.140 |
Why?
|
| Pesticides | 2 | 2010 | 30 | 0.140 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2018 | 42 | 0.140 |
Why?
|
| Adiponectin | 2 | 2008 | 21 | 0.140 |
Why?
|
| Dietary Supplements | 3 | 2008 | 131 | 0.140 |
Why?
|
| Monocytes | 1 | 2019 | 215 | 0.140 |
Why?
|
| Asthma | 2 | 2023 | 1039 | 0.140 |
Why?
|
| Comorbidity | 2 | 2013 | 1007 | 0.140 |
Why?
|
| Principal Component Analysis | 2 | 2010 | 167 | 0.140 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 1917 | 0.140 |
Why?
|
| Stroke | 5 | 2025 | 1079 | 0.140 |
Why?
|
| Adenosine | 1 | 2021 | 275 | 0.140 |
Why?
|
| Immunity | 1 | 2019 | 153 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2022 | 438 | 0.140 |
Why?
|
| Cooking | 3 | 2023 | 69 | 0.140 |
Why?
|
| Body Height | 2 | 2015 | 107 | 0.130 |
Why?
|
| Saliva | 1 | 2018 | 124 | 0.130 |
Why?
|
| Child Mortality | 1 | 2017 | 9 | 0.130 |
Why?
|
| Menopause | 3 | 2024 | 87 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 61 | 0.130 |
Why?
|
| Haplotypes | 3 | 2008 | 647 | 0.130 |
Why?
|
| Naltrexone | 1 | 2019 | 139 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 287 | 0.130 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 255 | 0.130 |
Why?
|
| Sleep | 1 | 2021 | 448 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2019 | 297 | 0.130 |
Why?
|
| Cluster Analysis | 3 | 2018 | 391 | 0.130 |
Why?
|
| Folic Acid Deficiency | 2 | 2008 | 6 | 0.130 |
Why?
|
| Dietary Exposure | 1 | 2017 | 2 | 0.130 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 65 | 0.130 |
Why?
|
| Hyperhomocysteinemia | 2 | 2008 | 11 | 0.130 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 170 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2021 | 457 | 0.130 |
Why?
|
| Activin Receptors, Type I | 3 | 2005 | 13 | 0.130 |
Why?
|
| Periodontal Diseases | 1 | 2016 | 10 | 0.120 |
Why?
|
| New York | 3 | 2015 | 76 | 0.120 |
Why?
|
| Global Burden of Disease | 1 | 2016 | 13 | 0.120 |
Why?
|
| Diet, Gluten-Free | 1 | 2017 | 60 | 0.120 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 1275 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2005 | 51 | 0.120 |
Why?
|
| Receptors, Progesterone | 2 | 2016 | 196 | 0.120 |
Why?
|
| Patient Selection | 1 | 2020 | 690 | 0.120 |
Why?
|
| Republic of Korea | 3 | 2024 | 37 | 0.120 |
Why?
|
| Selenium Compounds | 1 | 2016 | 3 | 0.120 |
Why?
|
| Macrophages | 1 | 2019 | 610 | 0.120 |
Why?
|
| Anions | 1 | 2016 | 30 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2019 | 463 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2016 | 129 | 0.120 |
Why?
|
| Parents | 1 | 2018 | 292 | 0.120 |
Why?
|
| Bile | 1 | 2016 | 60 | 0.120 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2015 | 9 | 0.120 |
Why?
|
| Quality of Life | 2 | 2015 | 1780 | 0.120 |
Why?
|
| Japan | 3 | 2024 | 299 | 0.120 |
Why?
|
| Cytochrome P-450 CYP1B1 | 2 | 2006 | 10 | 0.120 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 268 | 0.120 |
Why?
|
| Mammals | 1 | 2017 | 259 | 0.110 |
Why?
|
| Metabolic Syndrome | 1 | 2016 | 122 | 0.110 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 338 | 0.110 |
Why?
|
| Animals | 13 | 2024 | 28155 | 0.110 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2015 | 27 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2021 | 524 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 701 | 0.110 |
Why?
|
| Computational Biology | 1 | 2018 | 578 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 1133 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 43 | 0.110 |
Why?
|
| Spirituality | 1 | 2015 | 88 | 0.110 |
Why?
|
| Intelligence Tests | 4 | 2011 | 38 | 0.110 |
Why?
|
| Blotting, Southern | 1 | 2014 | 110 | 0.110 |
Why?
|
| Heterozygote | 3 | 2017 | 382 | 0.110 |
Why?
|
| Creatinine | 4 | 2008 | 293 | 0.110 |
Why?
|
| Drug Therapy, Combination | 2 | 2008 | 759 | 0.110 |
Why?
|
| Epistasis, Genetic | 2 | 2018 | 90 | 0.110 |
Why?
|
| Survivors | 1 | 2015 | 204 | 0.110 |
Why?
|
| Chemoprevention | 1 | 2014 | 93 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2008 | 917 | 0.110 |
Why?
|
| Interviews as Topic | 4 | 2011 | 364 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 105 | 0.110 |
Why?
|
| Reagent Strips | 1 | 2014 | 4 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2021 | 730 | 0.100 |
Why?
|
| Genetic Testing | 2 | 2010 | 565 | 0.100 |
Why?
|
| Models, Statistical | 3 | 2016 | 585 | 0.100 |
Why?
|
| Food Analysis | 2 | 2011 | 4 | 0.100 |
Why?
|
| Sex Characteristics | 2 | 2019 | 333 | 0.100 |
Why?
|
| Community Health Planning | 2 | 2011 | 22 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 876 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2016 | 85 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 985 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 894 | 0.100 |
Why?
|
| Organ Size | 1 | 2014 | 362 | 0.100 |
Why?
|
| Global Health | 1 | 2015 | 208 | 0.100 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 155 | 0.100 |
Why?
|
| Genetic Markers | 3 | 2020 | 469 | 0.100 |
Why?
|
| Tongue Diseases | 1 | 2013 | 9 | 0.100 |
Why?
|
| Stomatitis | 1 | 2013 | 30 | 0.100 |
Why?
|
| Social Behavior | 1 | 2015 | 307 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2015 | 260 | 0.090 |
Why?
|
| Databases, Genetic | 2 | 2012 | 282 | 0.090 |
Why?
|
| Chi-Square Distribution | 3 | 2011 | 356 | 0.090 |
Why?
|
| Epidemiological Monitoring | 2 | 2010 | 43 | 0.090 |
Why?
|
| Chromosome Mapping | 2 | 2022 | 1052 | 0.090 |
Why?
|
| Fishes | 2 | 2013 | 144 | 0.090 |
Why?
|
| Pedigree | 2 | 2004 | 961 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 307 | 0.090 |
Why?
|
| Genomics | 1 | 2018 | 848 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 884 | 0.090 |
Why?
|
| Motor Skills Disorders | 1 | 2011 | 14 | 0.090 |
Why?
|
| Child Development | 2 | 2011 | 166 | 0.090 |
Why?
|
| Manganese Poisoning | 1 | 2011 | 1 | 0.090 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 48 | 0.090 |
Why?
|
| Cucurbitaceae | 1 | 2010 | 4 | 0.080 |
Why?
|
| Urinalysis | 1 | 2011 | 34 | 0.080 |
Why?
|
| Motor Skills | 1 | 2011 | 77 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2010 | 39 | 0.080 |
Why?
|
| Body Weight | 3 | 2019 | 449 | 0.080 |
Why?
|
| Child Behavior | 1 | 2011 | 45 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 216 | 0.080 |
Why?
|
| India | 1 | 2011 | 139 | 0.080 |
Why?
|
| Bayes Theorem | 2 | 2025 | 402 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 302 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2013 | 493 | 0.080 |
Why?
|
| Poultry | 2 | 2024 | 22 | 0.080 |
Why?
|
| Protective Agents | 1 | 2010 | 34 | 0.080 |
Why?
|
| Metabolomics | 2 | 2023 | 98 | 0.080 |
Why?
|
| Energy Intake | 1 | 2010 | 97 | 0.080 |
Why?
|
| Seeds | 1 | 2010 | 62 | 0.080 |
Why?
|
| Therapeutics | 1 | 2010 | 13 | 0.080 |
Why?
|
| Nails | 2 | 2025 | 11 | 0.080 |
Why?
|
| Algorithms | 2 | 2022 | 1953 | 0.080 |
Why?
|
| Water | 1 | 2011 | 307 | 0.080 |
Why?
|
| Peroxidase | 2 | 2012 | 54 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 296 | 0.070 |
Why?
|
| Mutagens | 1 | 2009 | 29 | 0.070 |
Why?
|
| Oximetry | 1 | 2009 | 90 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 688 | 0.070 |
Why?
|
| Gamma Rays | 1 | 2009 | 73 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 41 | 0.070 |
Why?
|
| Healthy Volunteers | 2 | 2019 | 148 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 40 | 0.070 |
Why?
|
| Vitamin A | 1 | 2008 | 27 | 0.070 |
Why?
|
| Colon | 1 | 2012 | 540 | 0.070 |
Why?
|
| Electronic Health Records | 2 | 2022 | 372 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 42 | 0.070 |
Why?
|
| Dinoprost | 1 | 2008 | 27 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 78 | 0.070 |
Why?
|
| Physicians, Family | 1 | 2008 | 35 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 200 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 102 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2008 | 48 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2009 | 192 | 0.070 |
Why?
|
| Premenopause | 1 | 2007 | 63 | 0.070 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2007 | 4 | 0.070 |
Why?
|
| Linkage Disequilibrium | 2 | 2008 | 478 | 0.070 |
Why?
|
| Precision Medicine | 1 | 2012 | 456 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 166 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2019 | 756 | 0.070 |
Why?
|
| Choline | 1 | 2007 | 24 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2005 | 177 | 0.070 |
Why?
|
| Carcinogens | 2 | 2009 | 101 | 0.060 |
Why?
|
| Niacin | 1 | 2007 | 37 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2008 | 191 | 0.060 |
Why?
|
| X-Ray Absorption Spectroscopy | 2 | 2017 | 3 | 0.060 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 2006 | 3 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2005 | 272 | 0.060 |
Why?
|
| Waist-Hip Ratio | 2 | 2019 | 21 | 0.060 |
Why?
|
| Breast Feeding | 1 | 2008 | 100 | 0.060 |
Why?
|
| Waist Circumference | 2 | 2019 | 24 | 0.060 |
Why?
|
| Ownership | 1 | 2007 | 28 | 0.060 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 2 | 2003 | 4 | 0.060 |
Why?
|
| Hepatitis B, Chronic | 1 | 2007 | 34 | 0.060 |
Why?
|
| Genes, p53 | 2 | 2006 | 108 | 0.060 |
Why?
|
| Hydroxyestrones | 1 | 2006 | 4 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 410 | 0.060 |
Why?
|
| Infant | 2 | 2017 | 3220 | 0.060 |
Why?
|
| Population Groups | 1 | 2006 | 42 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2021 | 2026 | 0.060 |
Why?
|
| Codon | 1 | 2006 | 116 | 0.060 |
Why?
|
| Organometallic Compounds | 1 | 2007 | 139 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2019 | 9098 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2006 | 454 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 456 | 0.060 |
Why?
|
| Melanosis | 1 | 2005 | 6 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2017 | 2479 | 0.060 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2005 | 7 | 0.060 |
Why?
|
| Estradiol | 1 | 2006 | 247 | 0.060 |
Why?
|
| Mortality, Premature | 1 | 2025 | 6 | 0.060 |
Why?
|
| Carcinogens, Environmental | 1 | 2005 | 7 | 0.060 |
Why?
|
| Benchmarking | 1 | 2005 | 80 | 0.060 |
Why?
|
| New York City | 4 | 2008 | 69 | 0.060 |
Why?
|
| Base Sequence | 3 | 2021 | 2220 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2007 | 1713 | 0.060 |
Why?
|
| Nuclear Family | 1 | 2005 | 92 | 0.060 |
Why?
|
| Mercury | 1 | 2025 | 11 | 0.060 |
Why?
|
| Volatile Organic Compounds | 1 | 2024 | 4 | 0.060 |
Why?
|
| Environmental Pollution | 1 | 2004 | 13 | 0.060 |
Why?
|
| Silicones | 1 | 2024 | 21 | 0.060 |
Why?
|
| Wrist | 1 | 2024 | 29 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2007 | 298 | 0.050 |
Why?
|
| Multigene Family | 1 | 2025 | 203 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 589 | 0.050 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2005 | 91 | 0.050 |
Why?
|
| Systole | 1 | 2024 | 83 | 0.050 |
Why?
|
| Diastole | 1 | 2024 | 99 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 8 | 0.050 |
Why?
|
| Occupational Injuries | 1 | 2024 | 3 | 0.050 |
Why?
|
| Lead | 3 | 2011 | 32 | 0.050 |
Why?
|
| Genetic Privacy | 1 | 2023 | 12 | 0.050 |
Why?
|
| Resistin | 1 | 2023 | 12 | 0.050 |
Why?
|
| Catalase | 1 | 2003 | 46 | 0.050 |
Why?
|
| Workplace | 1 | 2024 | 33 | 0.050 |
Why?
|
| Ghrelin | 1 | 2023 | 27 | 0.050 |
Why?
|
| Soot | 1 | 2023 | 7 | 0.050 |
Why?
|
| Troponin | 1 | 2023 | 26 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2006 | 702 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 89 | 0.050 |
Why?
|
| Hormones | 1 | 2024 | 136 | 0.050 |
Why?
|
| Transportation | 1 | 2003 | 20 | 0.050 |
Why?
|
| Chromosomes, Human, Y | 1 | 2023 | 26 | 0.050 |
Why?
|
| Aminobiphenyl Compounds | 1 | 2003 | 1 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2023 | 67 | 0.050 |
Why?
|
| C-Peptide | 1 | 2023 | 184 | 0.050 |
Why?
|
| Leptin | 1 | 2023 | 100 | 0.050 |
Why?
|
| Registries | 2 | 2008 | 990 | 0.050 |
Why?
|
| Smokers | 1 | 2023 | 54 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2023 | 98 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2023 | 88 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 624 | 0.050 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2003 | 118 | 0.050 |
Why?
|
| RNA | 1 | 2007 | 573 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 347 | 0.050 |
Why?
|
| Adipocytes | 1 | 2024 | 169 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2004 | 236 | 0.050 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 101 | 0.050 |
Why?
|
| Mice | 4 | 2021 | 12269 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2003 | 174 | 0.050 |
Why?
|
| Coffee | 1 | 2022 | 10 | 0.050 |
Why?
|
| Panic Disorder | 1 | 2002 | 21 | 0.050 |
Why?
|
| Tea | 1 | 2022 | 19 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2023 | 276 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2023 | 179 | 0.050 |
Why?
|
| Marital Status | 1 | 2022 | 43 | 0.050 |
Why?
|
| Racism | 1 | 2024 | 104 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 193 | 0.050 |
Why?
|
| Mastication | 2 | 2014 | 78 | 0.050 |
Why?
|
| Research | 1 | 2003 | 251 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2024 | 347 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 162 | 0.040 |
Why?
|
| Singapore | 1 | 2021 | 14 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 198 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2020 | 1741 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2015 | 784 | 0.040 |
Why?
|
| Anxiety | 1 | 2024 | 337 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2024 | 219 | 0.040 |
Why?
|
| Vitamins | 1 | 2022 | 85 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2024 | 399 | 0.040 |
Why?
|
| Islam | 1 | 2022 | 34 | 0.040 |
Why?
|
| Liver | 2 | 2006 | 1210 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 74 | 0.040 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2021 | 14 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2022 | 93 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 37 | 0.040 |
Why?
|
| Sequestosome-1 Protein | 1 | 2021 | 23 | 0.040 |
Why?
|
| Biomass | 1 | 2021 | 43 | 0.040 |
Why?
|
| Vacuoles | 1 | 2021 | 48 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 103 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2024 | 477 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 383 | 0.040 |
Why?
|
| Epidermis | 1 | 2021 | 103 | 0.040 |
Why?
|
| Chromatin | 1 | 2024 | 440 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2002 | 170 | 0.040 |
Why?
|
| RNA Stability | 1 | 2021 | 97 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 557 | 0.040 |
Why?
|
| Medicaid | 1 | 2023 | 258 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 123 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2021 | 146 | 0.040 |
Why?
|
| Depression | 1 | 2024 | 544 | 0.040 |
Why?
|
| Immunochemistry | 1 | 2019 | 18 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2024 | 455 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2004 | 579 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 1 | 2019 | 51 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2015 | 293 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 103 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 537 | 0.040 |
Why?
|
| Clostridiales | 1 | 2019 | 18 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 375 | 0.040 |
Why?
|
| Attitude | 1 | 2020 | 132 | 0.040 |
Why?
|
| Metals, Heavy | 1 | 2019 | 17 | 0.040 |
Why?
|
| Cetylpyridinium | 1 | 2018 | 2 | 0.040 |
Why?
|
| Parturition | 1 | 2018 | 22 | 0.040 |
Why?
|
| Ions | 1 | 2019 | 78 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 696 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2022 | 378 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 292 | 0.040 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2018 | 14 | 0.040 |
Why?
|
| Hospitalization | 1 | 2004 | 937 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2018 | 81 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2021 | 408 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2018 | 200 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2018 | 41 | 0.030 |
Why?
|
| Penetrance | 1 | 2018 | 48 | 0.030 |
Why?
|
| Rats | 2 | 2016 | 4072 | 0.030 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2017 | 11 | 0.030 |
Why?
|
| Mesocricetus | 1 | 2017 | 102 | 0.030 |
Why?
|
| Synchrotrons | 1 | 2017 | 33 | 0.030 |
Why?
|
| Abortion, Therapeutic | 1 | 2017 | 11 | 0.030 |
Why?
|
| Stillbirth | 1 | 2017 | 14 | 0.030 |
Why?
|
| Coronary Disease | 2 | 2013 | 223 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2018 | 140 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 502 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2017 | 291 | 0.030 |
Why?
|
| Freezing | 1 | 2017 | 31 | 0.030 |
Why?
|
| Genes, p16 | 2 | 2007 | 10 | 0.030 |
Why?
|
| Longevity | 1 | 2017 | 60 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 337 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2011 | 10164 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 2017 | 73 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 166 | 0.030 |
Why?
|
| Cyclophilins | 1 | 2016 | 8 | 0.030 |
Why?
|
| Time Factors | 2 | 2015 | 5410 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 14 | 0.030 |
Why?
|
| Creatine | 2 | 2006 | 27 | 0.030 |
Why?
|
| Drug Antagonism | 1 | 2016 | 9 | 0.030 |
Why?
|
| Nutritional Status | 2 | 2007 | 79 | 0.030 |
Why?
|
| DNA Damage | 2 | 2009 | 389 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 1922 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 58 | 0.030 |
Why?
|
| Canada | 1 | 2015 | 194 | 0.030 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2015 | 2 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 300 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 502 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 307 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 96 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 1133 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 618 | 0.030 |
Why?
|
| Biological Assay | 1 | 2014 | 82 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 210 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 147 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2005 | 18 | 0.030 |
Why?
|
| Thigh | 1 | 2013 | 41 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 300 | 0.030 |
Why?
|
| Exercise | 1 | 2017 | 353 | 0.030 |
Why?
|
| Quality Control | 1 | 2014 | 123 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2015 | 470 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 215 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2014 | 159 | 0.020 |
Why?
|
| United States Environmental Protection Agency | 1 | 2013 | 4 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 572 | 0.020 |
Why?
|
| Mouth Diseases | 1 | 2013 | 14 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 887 | 0.020 |
Why?
|
| Cattle | 1 | 2013 | 397 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 449 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2013 | 71 | 0.020 |
Why?
|
| E-Selectin | 1 | 2012 | 31 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2012 | 84 | 0.020 |
Why?
|
| Tobacco, Smokeless | 1 | 2011 | 10 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 46 | 0.020 |
Why?
|
| Latin America | 1 | 2011 | 16 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 83 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2012 | 50 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 2011 | 6 | 0.020 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2011 | 5 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2012 | 83 | 0.020 |
Why?
|
| Mosaicism | 1 | 2012 | 73 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2011 | 16 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2012 | 109 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2011 | 50 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 214 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2011 | 33 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 809 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 308 | 0.020 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2011 | 17 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 1799 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 178 | 0.020 |
Why?
|
| Comprehension | 1 | 2011 | 82 | 0.020 |
Why?
|
| Geography | 1 | 2011 | 240 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2011 | 239 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 179 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 436 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2850 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 392 | 0.020 |
Why?
|
| Asbestos | 1 | 2009 | 20 | 0.020 |
Why?
|
| Family Health | 1 | 2009 | 153 | 0.020 |
Why?
|
| Memory | 1 | 2011 | 227 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1133 | 0.020 |
Why?
|
| Cricetulus | 1 | 2009 | 122 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2008 | 16 | 0.020 |
Why?
|
| CHO Cells | 1 | 2009 | 187 | 0.020 |
Why?
|
| Jews | 1 | 2008 | 42 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1721 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 1006 | 0.020 |
Why?
|
| Death Certificates | 1 | 2008 | 11 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2005 | 2017 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 532 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 45 | 0.020 |
Why?
|
| Tritium | 1 | 2007 | 116 | 0.020 |
Why?
|
| Nigeria | 1 | 2008 | 162 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 2007 | 30 | 0.020 |
Why?
|
| Aflatoxins | 1 | 2007 | 2 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 608 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1117 | 0.020 |
Why?
|
| Albumins | 1 | 2007 | 123 | 0.020 |
Why?
|
| Korea | 1 | 2005 | 18 | 0.010 |
Why?
|
| Fresh Water | 1 | 2005 | 22 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2008 | 3502 | 0.010 |
Why?
|
| Hypesthesia | 1 | 2005 | 14 | 0.010 |
Why?
|
| Toes | 1 | 2005 | 15 | 0.010 |
Why?
|
| Proprioception | 1 | 2005 | 24 | 0.010 |
Why?
|
| Hematinics | 1 | 2005 | 11 | 0.010 |
Why?
|
| Diet, Vegetarian | 1 | 2005 | 8 | 0.010 |
Why?
|
| Base Pair Mismatch | 1 | 2005 | 23 | 0.010 |
Why?
|
| Hand Strength | 1 | 2005 | 57 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 110 | 0.010 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2004 | 10 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 2004 | 12 | 0.010 |
Why?
|
| Micronutrients | 1 | 2004 | 18 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 2464 | 0.010 |
Why?
|
| Child Welfare | 1 | 2004 | 44 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 2910 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 216 | 0.010 |
Why?
|
| Eating | 1 | 2004 | 162 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 543 | 0.010 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2003 | 13 | 0.010 |
Why?
|
| Seasons | 1 | 2004 | 240 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 660 | 0.010 |
Why?
|
| DNA Repair | 1 | 2005 | 361 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2003 | 242 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2002 | 54 | 0.010 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2002 | 25 | 0.010 |
Why?
|
| Tobacco Products | 1 | 2003 | 77 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 531 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2002 | 146 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2002 | 156 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 295 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2002 | 517 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 1028 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 1546 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2002 | 219 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 140 | 0.010 |
Why?
|
| Prostatic Hyperplasia | 1 | 2002 | 95 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 376 | 0.010 |
Why?
|